Achmea Investment Management B.V. United Therapeutics Corp Transaction History
Achmea Investment Management B.V.
- $6.87 Billion
- Q1 2025
A detailed history of Achmea Investment Management B.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Achmea Investment Management B.V. holds 59,180 shares of UTHR stock, worth $17.9 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
59,180
Previous 36,746
61.05%
Holding current value
$17.9 Million
Previous $13 Million
40.71%
% of portfolio
0.27%
Previous 0.21%
Shares
16 transactions
Others Institutions Holding UTHR
# of Institutions
726Shares Held
40.8MCall Options Held
123KPut Options Held
100K-
Black Rock Inc. New York, NY5.47MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.35 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$837 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$667 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$633 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...